Too many drug types causing negative repercussions on heart health

Heart disease is the number one killer disease with about 80 million Americans suffering from this disease. Majority of patients suffering from heart disease are using multiple drugs that in turn are compromising the overall health of these heart patients. A number of leading cardiologists who attended the annual scientific sessions of the American College of Cardiology (ACC) that was held on March 9-11 in San Francisco has raised concerns with each of them voicing criticism over the use of multiple drugs in the treatment of heart disease.

The cardiologists opined that eliminating certain drugs would potentially improve care without compromising on the treatment related with heart disease. As evidence is emerging that, some medications are not effective. According to Dr. Steven Nissen – Head of the Cardiology at the Cleveland Clinic and past president of the ACC, he cast doubt whether the benefits are additive or not. The cardiologists are giving a second look on certain medications that include AbbVie’s Niaspan or prescription drug niacin that aims to raise good cholesterol. The other well known so called fenofibrate such as the top selling branded drug TriCor (also from the stables of AbbVie) that lowers the blood fats called triglycerides and beta blockers most of which are inexpensive older generics are also under the scanner of these cardiologists.


Switch to our mobile site